Top-News

Aratana Therapeutics News

Keine aktuellen Kursdaten verfügbar
WKN: A1W10A
ISIN: US03874P1012
US-Symbol: PETX
Typ: Aktie

Aratana Therapeutics News

16.07.19 - PR Newswire
Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health
Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health Aratana Reports Voting Results from 2019 Special Meeting of Stockholders PR Newswire
11.06.19 - PR Newswire
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial Commercial availability of NOCITA 10 mL vial size anticipated by ...
07.06.19 - PR Newswire
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders Stockholders Elect All Class III Directors and Approve Proposals PR Newswire
13.05.19 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype Imaging Holdings, Inc., PetIQ, Inc., and Pinduoduo, Inc.
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype ...
08.05.19 - PR Newswire
Aratana Therapeutics Reports First Quarter 2019 Financial Results
Aratana Therapeutics Reports First Quarter 2019 Financial Results Continued revenue growth across portfolio of marketed pet therapeutics PR Newswire
07.05.19 - PR Newswire
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference PR Newswire
03.05.19 - PR Newswire
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Buyout
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Buyout PR Newswire
29.04.19 - PR Newswire
Thinking about buying stock in Aurora Cannabis, The Walt Disney Co., Aratana Therapeutics, Regional Health Properties, or Spotify?
Thinking about buying stock in Aurora Cannabis, The Walt Disney Co., Aratana Therapeutics, Regional Health Properties, or Spotify? PR Newswire
26.04.19 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. PR Newswire
26.04.19 - PR Newswire
Aratana Therapeutics to be Acquired by Elanco Animal Health
Aratana Therapeutics to be Acquired by Elanco Animal Health Elanco announces formation of commercial team dedicated to veterinary specialty business PR Newswire
22.04.19 - PR Newswire
Aratana Therapeutics to Report First Quarter 2019 Financial Results
Aratana Therapeutics to Report First Quarter 2019 Financial Results PR Newswire
12.03.19 - PR Newswire
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results PR Newswire
13.02.19 - PR Newswire
Aratana Therapeutics to Participate at Upcoming Investment Conferences
Aratana Therapeutics to Participate at Upcoming Investment Conferences PR Newswire
12.02.19 - PR Newswire
Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results PR Newswire
04.02.19 - PR Newswire
Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer
Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer PR Newswire
17.01.19 - PR Newswire
Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer
Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer PR Newswire
01.11.18 - PR Newswire
Aratana Therapeutics Reports Third Quarter 2018 Financial Results
Aratana Therapeutics Reports Third Quarter 2018 Financial Results PR Newswire
22.10.18 - PR Newswire
Aratana Therapeutics to Report Third Quarter 2018 Financial Results
Aratana Therapeutics to Report Third Quarter 2018 Financial Results PR Newswire
29.08.18 - PR Newswire
Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference
Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference PR Newswire
02.08.18 - PR Newswire
Aratana Therapeutics Reports Second Quarter 2018 Financial Results
Aratana Therapeutics Reports Second Quarter 2018 Financial Results PR Newswire

Newssuche

Videos

newspaper
09:10 Uhr
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »